Halozyme Therapeutics Inc (HALO): Chemophase trial updated June 29. Dat...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	1139
Boards Moderated	0
Alias Born	04/27/2006

rod5247

Re: None

Tuesday, 07/03/2007 3:54:05 PM

Tuesday, July 03, 2007 3:54:05 PM

Chemophase trial updated June 29.

Data updated Friday and Halozyme stated expected completed enrollment Q3.

http://clinicaltrials.gov/ct/show/NCT00318643?order=3

"Study ID Numbers: HZ2-05-01
Last Updated: June 29, 2007
Record first received: April 25, 2006
ClinicalTrials.gov Identifier: NCT00318643
Health Authority: United States: Food and Drug Administration"

Preliminary data from this trial and the announcement of the next trial design should be a price mover. If efficacy is shown, they will probabley release full data at a cancer conferance. Should see some milestone payments this Q. The second half is what I have been waiting for and it is starting.

Viscous Antibody study completed in May.

http://clinicaltrials.gov/ct/show/NCT00435604?order=4

Good Luck

Rod

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.